The value of serial echocardiography in risk assessment of patients with paroxysmal atrial fibrillation

被引:2
|
作者
Leung, Melissa [1 ,2 ]
van Rosendael, Philippe J. [1 ]
van der Bijl, Pieter [1 ]
Regeer, Madelien V. [1 ]
van Wijngaarden, Suzanne E. [1 ]
Leung, Dominic Y. [2 ]
Delgado, Victoria [1 ]
Marsan, Nina Ajmone [1 ]
Ng, Arnold C. T. [3 ]
Bax, Jeroen J. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
[2] Univ New South Wales, Liverpool Hosp, Ingham Inst Appl Med Res, Dept Cardiol, Sydney, Australia
[3] Univ New South Wales, Sydney, Australia
来源
关键词
Atrial fibrillation; Left atrium; Strain; Tissue Doppler imaging; CONSENSUS STATEMENT; HEART-FAILURE; PERSISTENT; STROKE; PROGRESSION; ASSOCIATION; PREDICTORS; MANAGEMENT; ABLATION; SOCIETY;
D O I
10.1007/s10554-023-03014-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Progression from paroxysmal to persistent atrial fibrillation (AF) is associated with increased morbidity and mortality. We examined the association of left atrial (LA) remodeling by serial echocardiography, and AF progression over an extended follow-up period. Two-hundred ninety patients (mean age 61 +/- 11 years, 73% male) who underwent transthoracic echocardiography performed at first presentation for non-valvular paroxysmal AF (PAF) and repeat echocardiogram 1-year later, were followed for progression to persistent AF. LA and left ventricular (LV) dimensions, volumes, LA reservoir, conduit and booster pump strains, LV global longitudinal systolic strain (GLS) assessed by 2D speckle tracking, and PA-TDI (time delay between electrical and mechanical LA activation- reflecting the extent of LA fibrosis) were compared on serial echocardiography. Sixty-nine (24%) patients developed persistent AF over a mean follow-up period of 6.3 years. At baseline, patients with subsequent persistent AF had larger LA dimensions (46 mm vs. 42 mm, p < 0.001), indexed LA volumes (41 ml/m(2) vs. 34 ml/m(2), p < 0.001), lower LA reservoir and conduit strain (17.6% vs. 27.6%, p < 0.001; 10.5% vs. 16.3%, p < 0.001; respectively) and longer PA-TDI (155 ms vs. 132 ms, p < 0.001) compared to the PAF group. Patients with subsequent persistent AF showed over time significant enlargement in LA volumes (from 37.7 ml/m(2) to 42.4 ml/m(2), p < 0.001), lengthening of PA-TDI (from 142.2 ms to 162.2 ms, p = 0.002), and decline in LA reservoir function (from 21.9% to 18.1%, p = 0.024) after adjusting for age, gender, diabetes and LV GLS. There were no changes in LA diameter, LA conduit or booster pump function. Conversely, the PAF group showed no decline in LA function. Patients who developed persistent AF had larger LA size and impaired LA function and atrial conduction times at baseline, compared to patients who remained PAF. Over the 1-year time course of serial echocardiographic evaluation, there was progression of LA remodeling in patients who subsequently developed persistent AF, but not in patients who remained in PAF.
引用
收藏
页码:499 / 508
页数:10
相关论文
共 50 条
  • [31] First clinical trial of specific IKACh blocker shows no reduction in atrial fibrillation burden in patients with paroxysmal atrial fibrillation: pacemaker assessment of BMS 914392 in patients with paroxysmal atrial fibrillation
    Podd, Steven J.
    Freemantle, Nicholas
    Furniss, Stephen S.
    Sulke, Neil
    EUROPACE, 2016, 18 (03): : 340 - 346
  • [32] Assessment of left atrial remodeling in paroxysmal atrial fibrillation with speckle tracking echocardiography: a study with an electrophysiological mapping system
    Yilin Chen
    Zheng Li
    Xuedong Shen
    Wei Wang
    Yu Kang
    Zhiqing Qiao
    Xinhua Wang
    Jun Pu
    The International Journal of Cardiovascular Imaging, 2019, 35 : 451 - 459
  • [33] Risk factors for atrial fibrillation recurrence after cryoballoon catheter ablation in patients with paroxysmal atrial fibrillation
    Zhou, Jin
    Xu, Jing
    Sun, Shan
    Cheng, Aijuan
    Li, Peng
    Ding, Jun
    Yang, Peigen
    Zhang, Zhiyuan
    Fang, Tao
    Yan, Yingchuan
    Cong, Hongliang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (10): : 11205 - 11210
  • [34] Transesophageal echocardiography in high-risk patients with atrial fibrillation
    Tunick, PA
    Kronzon, I
    ANNALS OF INTERNAL MEDICINE, 1998, 129 (09) : 748 - 748
  • [35] Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation
    Stöllberger, C
    Chnupa, P
    Kronik, G
    Brainin, M
    Finsterer, J
    Schneider, B
    Slany, J
    ANNALS OF INTERNAL MEDICINE, 1998, 128 (08) : 630 - +
  • [36] Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk?
    Lip, GYH
    LANCET, 1997, 349 (9065): : 1565 - 1566
  • [37] Hypoadiponectinemia in Patients With Paroxysmal Atrial Fibrillation
    Choi, Byung Joo
    Heo, Jung Ho
    Choi, In-Soo
    Lee, Si-Won
    Kim, Hyun-Soo
    Lee, Jae Woo
    Cha, Tae-Joon
    KOREAN CIRCULATION JOURNAL, 2012, 42 (10) : 668 - 673
  • [38] Assessment of cardiac autonomic function in patients with permanent and paroxysmal atrial fibrillation
    Khan, A. A.
    Junejo, R. T.
    Thomas, G. N.
    Fisher, J. P.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2021, 42 : 426 - 426
  • [39] Echocardiographic assessment of atrial function in patients with hypertrophic cardiomyopathy with and without paroxysmal atrial fibrillation
    Morbeck Teixeira, Kamilla Leite
    Correia, Edileide de Barros
    Tressino, Cintia Galhardo
    Pecanha, Marcela Momesso
    Melchior, Walter Antonio
    de Mattos Barretto, Rodrigo Bellio
    de Medeiros, Bruna Gomes
    Le Bihan, David
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2022, 41 (09) : 771 - 779
  • [40] ATRIAL-FIBRILLATION - THE VALUE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY
    ERBEL, R
    SCHON, F
    LEISCHIK, R
    VONBIRGELEN, C
    ZEPPELINI, R
    ZEITSCHRIFT FUR KARDIOLOGIE, 1994, 83 : 41 - 47